Medical network - March 7th national annual per year, as China's top medical apparatus and instruments of corporate attendees, deputy to the National People's Congress, shandong xinhua medical instrument co., LTD., chairman of Zhao Yixin, can put forward many Suggestions for the problems. In 2017 the two sessions, Zhao Yixin to claim what again?
On March 4, the industry to the National People's Congress, CPPCC member symposium was held in Beijing. It is understood that at the meeting Zhao Yixin expounds the new problems in the development of the medical treatment apparatus profession, the call for governments at all levels and relevant departments to develop a good policy, promoting the development of medical equipment industry.
Zhao Yixin also at the conference is "about to formulate reasonable fees, reduce the corporate tax rate, to support the development of in vitro diagnostic industry proposal", the sales situation about domestic high-end medical equipment enterprises, set up collaboration platform construction and protection of intellectual property rights advice ", "about to speed up the innovation of medical equipment products into the clinical use of the new policy Suggestions, such as hot issue filed a complaint.
Some of their claims are as follows:
One, to the IVD enterprises tax cuts
Zhao Yixin advice, the current VAT rates high, enterprise management burden is heavy, in the face of opportunities and challenges, more need to encourage and support from the government.
To its place of in vitro diagnostic reagent industry, the industry profit margins are relatively high, value-added tax, the real economy at the same time operating burden is heavy, industry raw material costs, product prices are lower, loan financing difficulties, enterprises encountered new difficulties, combined with the market expectations of tax cuts and the global impact, these changes reduce the industry enterprise competitiveness, some companies hard to survive.
Second, to speed up innovation in clinical medical devices using new policy
Zhao Yixin: in the popular business, big peoples innovation of national policies, the innovation of the medical device industry policy also appear constantly, especially the state food and drug supervision and management of the administration of innovative products to speed up the approval policy, promoted the enterprise research and development innovation, but the policy currently only stays in the upstream, innovation of medical equipment products is difficult to enter the market, cannot be used in clinical. To actively carry out technological innovation and entrepreneurship of new medical equipment enterprise is a big blow.
She called for, to accelerate the innovation of medical equipment products into the clinical use of the new policy, make innovative medical devices used for clinical purposes as soon as possible, disease diagnosis and treatment to reduce costs, reduce the financial burden on patients with diagnosis and treatment and national health insurance payment pressure. |
